SLS Cell Cure Technologies Private Limited
About SLS Cell Cure Technologies Private Limited
Data last updated:
SLS Cell Cure Technologies Private Limited was a private limited company based in Secunderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 28 September 2012.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2012PTC083318.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Shivraj Livy and Smita Shivraj Dasari.
Its last annual general meeting (AGM) was held on 28 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Flat No. 103 Prabhat Apartments Street No 11 East Maredpally, Secunderabad, Telangana, India – 500026.
As per the financials filed for FY 2017, the company reported a revenue of ₹10,000. For the same year it recorded a net loss of ₹1.11 Lakh and EBITDA of -₹48,329 (EBITDA margin -483.3%).
Company details
CIN history
SLS Cell Cure Technologies has one previous CIN (Corporate Identification Number): U73100AP2012PTC083318. The current CIN is U73100TG2012PTC083318, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2012PTC083318 | Current |
| U73100AP2012PTC083318 | Previous |
Contact details
SLS Cell Cure Technologies Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 103 Prabhat Apartments Street No 11 East Maredpally, Secunderabad, Telangana, India – 500026
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of SLS Cell Cure Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of SLS Cell Cure Technologies Private Limited
FY 2019 filings availableSLS Cell Cure Technologies Private Limited reported revenue of ₹10,000 for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹10,000 | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹48,329 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.11 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -483.3% | ||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of SLS Cell Cure Technologies Private Limited, buy the company report.
Board of directors of SLS Cell Cure Technologies Private Limited
SLS Cell Cure Technologies has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivraj Livy | Director | 28 Sep 2012 | 14 Years 1 Months | As last reported |
| Smita Shivraj Dasari | Director | 26 Dec 2018 | 7 Years 10 Months | As last reported |
Auditor
SLS Cell Cure Technologies Private Limited is audited by V S R A & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V S R A & ASSOCIATES | FY 2017 | 016159S |
Shareholding
The shareholding of SLS Cell Cure Technologies Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of SLS Cell Cure Technologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SLS Cell Cure Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SLS Cell Cure Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for SLS Cell Cure Technologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SLS Cell Cure Technologies Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Smita Shivraj Dasari ceased to be Additional Director on 28 Sep 2019.
Frequently asked questions
SLS Cell Cure Technologies has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
SLS Cell Cure Technologies was a private limited company based in Secunderabad, Telangana, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 28 September 2012 and is registered under CIN U73100TG2012PTC083318. The company has been struck off by the Registrar of Companies and is no longer operational.
SLS Cell Cure Technologies had 2 directors:
- Shivraj Livy - Director
- Smita Shivraj Dasari - Director
The CIN (Corporate Identification Number) of SLS Cell Cure Technologies is U73100TG2012PTC083318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of SLS Cell Cure Technologies is at Flat No. 103 Prabhat Apartments Street No 11 East Maredpally, Secunderabad, Telangana, India – 500026.
SLS Cell Cure Technologies was incorporated on 28 September 2012. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of SLS Cell Cure Technologies on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 28 September 2019. Year-wise statements from 2015 are in the company report.
SLS Cell Cure Technologies operated in the healthcare industry, in the other hospital and medical care activities segment. It worked in this industry before it was struck off.
Smita Shivraj Dasari ceased to be Additional Director on 28 Sep 2019. Smita Shivraj Dasari was appointed as Director on 26 Dec 2018. Shivraj Dasari ceased to be Director on 04 Sep 2018. SLS Cell Cure Technologies has 4 board changes on record in total.
The compliance status of SLS Cell Cure Technologies is compliant as of 23 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
